Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Liberty vs Wisp

Liberty
Graded #304

Lower grade

vs+3.4000000000000057
Wisp
Graded #243

Higher grade

The verdict

Wisp takes it — 64.4/100 to 61/100.

Wisp grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Wisp (hellowisp.com) is a US telehealth provider whose weight care vertical offers brand-name Wegovy, Zepbound, and Saxenda alongside a compounded sublingual semaglutide drops formulation at $225/month.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueWisp +6
44
50
Dose & formulationLiberty +1
77
76
Clinical oversightWisp +6
76
82
Labs & monitoringLiberty +1
54
53
FulfillmentLiberty +15
81
66
Contract termsWisp +35
20
55
Liberty · left barWisp · right bar

The numbers

MetricLibertyWisp
WeighScore61/10064.4/100
GradeCC
Scorecard rank#304#243
Semaglutide$199/mo (compounded)$225/mo (compounded oral)
Tirzepatide$299/mo (compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessYesYes
Oral / sublingualInjection onlyYes
Liberty

Graded #304 · C

Strengths

  • Compounded GLP-1 sourced from FDA-registered 503B outsourcing facilities, a stricter standard than the 503A pharmacies many competitors use
  • Transparent flat pricing: compounded semaglutide $199/mo (about $171/mo on a 3-month supply) and tirzepatide $299/mo
  • Nationwide in all 50 states with free discreet shipping, 24/7 support, and FSA/HSA acceptance
  • Multi-vertical menu beyond weight loss (low-dose microdosing, NAD+, sermorelin, metformin) for patients who want bundled wellness care

Where it loses points

  • Does not name its specific compounding pharmacy partner, only that it is a 503B facility
  • Tirzepatide at $299/mo is mid-market rather than the cheapest option among compounded providers
  • Generic corporate branding (Liberty Health) with limited public detail on the operating entity
  • Compounded medication only — no brand-name or insurance-covered GLP-1 path
Wisp

Graded #243 · C

Strengths

  • Broad GLP-1 menu — branded injectables (Wegovy, Zepbound, Saxenda) plus a compounded sublingual option
  • LegitScript certified with named board-certified providers (Dr. Shannon Chatham DO, Andrea Sleeth WHNP-BC)
  • Unusually candid about the sublingual option's limits, noting effectiveness in patients may vary

Where it loses points

  • The $99/mo tirzepatide figure is a consultation-and-care subscription, not the medication: Zepbound is filled at a pharmacy of your choice at its own cost, which Wisp does not publish
  • The compounded semaglutide option is sublingual drops, which Wisp itself describes as less effective than injection
  • Brand-name access is a prescription, not a dispensed product, so the drug cost is outside anything quoted here

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard